- Kurapa
- Uchapupu
- Neuroblastoma
- Gomarara Rakasimba
- Uchapupu
- TILS
- Kurapa Masero eNK
- Myasthenia Gravis (MG)
- Acute Lymphoblastic Leukemia (B-ALL)
- Systemic Lupus Erythematosus (SLE)
- Chirwere cheAcute Lymphoblastic Leukemia (T-ALL)
- Non Hodgkin Lymphoma (NHL)
- Multiple Myeloma (MM)
- Kuparadzira Lymphom yeB-cell yakakura
- B-lymphocytic Leukemia
- Myeloma
Chirwere cheAcute Lymphoblastic Leukemia (T-ALL)-03
Zvimiro zveNyaya:
- Kuongororwa: Acute T-cell lymphoblastic leukemia
- Kutanga uye Zviratidzo: Kubvumbi 2020, airatidza dzungu, kuneta, uye kubuda ropa paganda. Akaonekwa aine chirwere cheT-cell lymphoblastic leukemia kuburikidza nekuongororwa kweMICM yemumaronda emapfupa.
- Kurapwa kwekutanga: Kuwana relieve yakakwana (CR) mushure meVDCLP regimen chemotherapy, zvichiteverwa nematanho maviri ekuwedzera chemotherapy.
- Chikunguru 19, 2020: Ndakagamuchira allogeneic hematopoietic stem cell transplantation kubva kumupi wechikadzi (HLA 5/10 A donor A). Nzira yekurapa yaisanganisira kupiswa kwemuviri wese (TBI), cyclophosphamide (CY), uye etoposide (VP-16). Masero emuviri akaisirwa musi wa24 Chikunguru, nekudzorerwa kwegranulocyte pazuva +10 uye kuisirwa kweplatelet pazuva +13. Kuongororwa kwevarwere vanobuda kunze kwemuviri nguva dzose mushure mezvo.
- Kukadzi 25, 2021: Kudzoka kwemubofu mumwongo kwakaonekwa panguva yekutevera.
- Kurapa: Takatanga kurapwa nemuromo nethalidomide.
- Kurume 8: Ndakapinda muchipatara chedu.
- Maumbirwo eBone Morrow: 61.5% kuputika.
- Kupatsanurwa kweRopa rePanze: 15% kuputika.
- Immunophenotyping: 35.25% masero ane CD99, CD5, CD3dim, CD8dim, CD7, cCD3, CD2dim, HLA-ABC, cbcl-2, CD81, CD38, zvichiratidza kuti T lymphocytes dzisina kukura zvakanaka.
- Kuongorora maChromosome: 46, XX [9].
- Leukemia Fusion Gene: SIL-TAL1 fusion gene yakanaka; chiyero chehuwandu: SIL-TA.
- Kuchinja kweBundu reRopa: Negative.
- Kuongororwa kweChimerism (post-HSCT): Masero anobva kune vanopa aisvika 45.78%.
- Kurume 11: Kuunganidzwa kwemasero eropa ega ega ega eCD7-CART.
- Kurapa: Mishonga yeVILP (VDS 4mg, IDA 10mg, L-asparaginase 10,000 IU qd x mazuva mana, Dex 9mg q12h x mazuva mapfumbamwe) pamwe chete nethalidomide kudzora bundu.
- Kurume 19: Kurapwa kweFC regimen chemotherapy (Flu 50mg x mazuva matatu, CTX 0.4gx mazuva matatu).
- Kurume 24 (kusati kwaiswa mushonga): Maumbirwo emapfupa emubofu akaratidza giredhi V hyperplasia, ne22% yekuputika.
- Kuyerera kweBone Marrow Cytometry: 29.21% masero (emasero ane nucleated) anotsanangura CD3, CD5, CD7, CD99, anotsanangura cCD3 zvishoma, zvichiratidza masero eT asina kukura zvakanaka.
- Huwandu hweSIL-TAL1 Fusion Gene: 1.913%.
tsananguro2
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

